Higher antipsychotic doses are more likely to elevate prolactin. Enter: Vitamin B6.

If approved, this alternative to IV brexanolone will be a more practical option for treating PPD.

Randomized controlled trials have not been kind to commercial pharmacogenetic panels, but will Genecept’s fate be any different?

We live in a world where we are inundated with research studies and it is our job to vet these, looking for the pearls among the rocks. This article is a concise and practical review of what research can and cannot tell you and what to look for in a good study.

Medications don’t have a good track record in PTSD, particularly in combat related trauma. Here we review two controlled trials where an old standby (mirtazapine) and a hopeful contender (riluzole) come up short.

This first-of-its-kind study looked at lightbox in PTSD with a randomized, placebo-controlled design.

We are getting more comfortable with telemedicine-based platforms to provide care. But do they improve the quality of care for unhealthy alcohol use? This randomized, controlled trial compares in-person care with asynchronous, module-based care for people with alcohol use disorder.

Adherence may often limit effectiveness of medications for opioid use disorder among youth. In this randomized controlled trial, young adults with opioid use disorder were randomized to either youth opioid recovery support (an assertive intervention designed to increase adherence) or treatment as usual, both involving extended-release naltrexone.